Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Oct 8;17:17562864241277736. doi: 10.1177/17562864241277736

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2024

This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Outcomes and action taken with OCR following all infections and SIs, excluding COVID-19. (a) Length of hospitalization for SIs requiring admission to hospital (n = 545/583) in patients with RMS and PMS. (b) Outcomes of infections in patients with RMS and PMS; for SIs, fatal cases include pneumonia (n = 2), sepsis (n = 2), encephalitis (n = 1), enterococcal infection (n = 1), pneumonia aspiration (n = 1), and urosepsis (n = 1). (c) Action taken with OCR following infections in patients with RMS and PMS. CCOD, November 2022.

CCOD, clinical cut-off date; COVID-19, coronavirus disease 2019; N/A, not applicable; OCR, ocrelizumab; PMS, progressive multiple sclerosis; RMS, relapsing multiple sclerosis; SI, serious infection.